 "Torrent Pharma records over four-fold jump in Q3 profit at Rs 246 crore")
Drug firm Torrent Pharmaceuticals on Wednesday reported an over four-fold jump in consolidated net profit to Rs 246 crore for the December 2018 quarter.
It had posted a net profit of Rs 58 crore in the corresponding period of 2017-18, the company said in a BSE filing.
Consolidated revenue from operations stood at Rs 2,051 crore for the quarter, against Rs 1,463 crore a year ago.
In a separate filing, the company said its board has approved an interim dividend of Rs 13 per equity share.
The company said its board has recommended to members to obtain enabling approval for issuance of equity shares including convertible bonds/debentures through qualified institutional placement and/or depository receipts or any other modes for an amount not exceeding Rs 5,000 crore through postal ballot.
Shares of Torrent Pharmaceuticals closed at Rs 1,851.55 per scrip on the BSE, down 1.28 per cent from the previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app